• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Tunisian Study Links Clinical Features to Spinal Infection Types

by
November 9, 2026
in Health
Reading Time: 3 mins read
0
Tunisian Study Links Clinical Features to Spinal Infection Types

Tunisian Study Links Clinical Features to Spinal Infection Types

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a bicentric retrospective study conducted in Tunisia, researchers identified distinct clinical, laboratory, and radiological profiles that differentiate pyogenic spondylodiscitis from specific spondylodiscitis caused by tuberculosis or brucellosis. The study, published in Advances in Rheumatology, analyzed 131 patients diagnosed between 2012 and 2024 in the Rheumatology and Infectious Diseases departments of Mahdia and Monastir. The cohort included 86 patients with pyogenic spondylodiscitis and 45 with specific spondylodiscitis, providing a comparative basis for identifying diagnostic markers in a region where both tuberculosis and brucellosis are endemic. The primary objective was to determine features that enable accurate pathogen differentiation in cases where microbiological confirmation is lacking, a common challenge in clinical practice.

The study design involved a retrospective review of patient records to integrate clinical, biological, radiological, and microbiological criteria for diagnosis. This approach allowed the researchers to examine a broad range of variables, including demographic factors, symptom onset, laboratory markers, and imaging findings. By comparing the two groups, the team aimed to delineate patterns that could assist clinicians in forming pre-test clinical suspicion.

Demographic and clinical comparisons revealed significant differences between the two groups. Pyogenic spondylodiscitis predominantly affected older patients, with a median age of 64 years compared to 50 years for specific spondylodiscitis, a difference that was statistically significant. The onset of symptoms was also distinct, with acute presentation observed in 58.1% of pyogenic cases versus 24.4% of specific cases. Additionally, patients with pyogenic spondylodiscitis had shorter consultation delays, averaging 30 days from symptom onset to medical consultation, compared to 90 days for those with specific spondylodiscitis. These temporal and demographic patterns suggest that the speed of presentation and age of the patient may serve as initial clues in the diagnostic process.

Laboratory findings further highlighted the divergence between the two conditions. Patients with pyogenic spondylodiscitis exhibited significantly elevated inflammatory markers, including a median C-reactive protein level of 90.36 mg/L compared to 28 mg/L in the specific group, and a median erythrocyte sedimentation rate of 92.7 mm/h compared to 59.3 mm/h. Comorbidities also differed markedly, with a higher prevalence of diabetes mellitus in the pyogenic group (44.7%) than in the specific group (13.3%). Renal failure was also more common in pyogenic cases, occurring in 14% of patients compared to 2.2% in the specific group. These laboratory and comorbidity profiles indicate that pyogenic spondylodiscitis is often associated with a more acute inflammatory response and a higher burden of chronic metabolic and renal conditions.

Radiological and epidemiological factors provided additional distinguishing features. Specific spondylodiscitis showed a higher prevalence in rural populations, with 68.9% of patients from rural areas compared to 50% in the pyogenic group. Socioeconomic status was also lower in the specific group, a difference that was statistically significant. Symptomatically, night sweats were more frequent in specific spondylodiscitis (48.9%) than in pyogenic cases (29.1%).

Microbiological data, where available, confirmed the predominance of Staphylococcus aureus in pyogenic spondylodiscitis. In the 43 microbiologically confirmed pyogenic cases, which represented 50.0% of that group, Staphylococcus aureus was the most frequently isolated pathogen, accounting for 62.8% of isolates. The duration of antimicrobial therapy also varied significantly between the groups, with pyogenic spondylodiscitis requiring an average of 104 days of treatment compared to 270 days for specific spondylodiscitis.

Clinical outcomes were generally favorable in both groups, with 83.7% of pyogenic patients and 93.3% of specific patients achieving favorable results. However, mortality was observed exclusively in the pyogenic group, with an overall cohort mortality rate of 3.8% (5 out of 131 patients). Within the pyogenic group, the mortality rate was 5.8% (5 out of 86 patients).

Statistical modeling identified several independent associations with the specific etiologies. In multivariable models, diabetes mellitus, advanced age, and elevated erythrocyte sedimentation rate remained independently associated with pyogenic spondylodiscitis. Conversely, the presence of vertebral cystic lesions on plain radiography was independently associated with specific spondylodiscitis. The study acknowledges limitations, including its retrospective design and the considerable proportion of cases lacking microbiological confirmation. Therefore, the results should be interpreted as clinically informative associations rather than a validated diagnostic algorithm, necessitating confirmation in larger prospective cohorts.

The study contributes to the understanding of infectious spondylodiscitis in endemic settings by delineating distinct profiles for pyogenic and specific etiologies. Recognition of these differential presentations may refine pre-test clinical suspicion and facilitate earlier initiation of appropriate empirical therapy while awaiting microbiological confirmation. The findings highlight the utility of integrating demographic, clinical, laboratory, and radiological data in the diagnostic process.

Subject of Research: Comparative clinical and radiological features of pyogenic versus specific spondylodiscitis in a Tunisian population

Article Title: Pyogenic versus tuberculous and brucellar spondylodiscitis in a Tunisian population: a bicentric comparative study

Article References: Jomaa, O., Bougossa, R., Baccouche, S., Ardhaoui, M., Sarraj, R., Brahem, M., Abdellatif, S., Chekaya, N. B., Jguirim, M., Bejia, I., Elarbi, F., & Younes, M. (2026). Pyogenic versus tuberculous and brucellar spondylodiscitis in a Tunisian population: a bicentric comparative study. Advances in Rheumatology. https://doi.org/10.1186/s42358-026-00590-8

Image Credits: AI Generated

DOI: 10.1186/s42358-026-00590-8

Keywords: spondylodiscitis, infectious disease, tuberculosis, brucellosis, pyogenic infection, spinal infection, diagnostic markers, retrospective study, Tunisia, rheumatology, Pyogenic, versus

News Source: Kristina Jarvis. (November 9, 2026). Tunisian Study Links Clinical Features to Spinal Infection Types. Scienmag.

Tags: brucellosisdiagnostic markersinfectious diseasepyogenicpyogenic infectionRetrospective studyrheumatologyspinal infectionspondylodiscitisTuberculosisTunisiaversus
Share12Tweet7Share2ShareShareShare1

Related Posts

Engineered Myeloid Progenitor Platform Overcomes Allogeneic Barriers in CNS Tumors

Engineered Myeloid Progenitor Platform Overcomes Allogeneic Barriers in CNS Tumors

November 16, 2026
Physician Specialty Distribution Lags Behind Global Demographic Aging Trends

Physician Specialty Distribution Lags Behind Global Demographic Aging Trends

November 16, 2026

New Journal Leadership Outlines Strategy for Equitable Global LGBTQ+ Health Research

November 16, 2026

Milled Anterior Mock-Ups Achieve Higher Surface Matching Than Conventional Impressions

November 16, 2026

POPULAR NEWS

  • Engineered Myeloid Progenitor Platform Overcomes Allogeneic Barriers in CNS Tumors

    Engineered Myeloid Progenitor Platform Overcomes Allogeneic Barriers in CNS Tumors

    29 shares
    Share 12 Tweet 7
  • Physician Specialty Distribution Lags Behind Global Demographic Aging Trends

    29 shares
    Share 12 Tweet 7
  • Rapid In Planta Citrus Transformation System Enables Efficient Genome Editing

    29 shares
    Share 12 Tweet 7
  • Simulated Reinforcement Learning Model Improves 4G LTE Handover Success and Reliability

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

BRCA1/2 Carriers View Emerging Cancer Tests as Secondary to Surgical Decisions

Review Outlines Dual Protumor and Antitumor Roles of TBK1 in Cancer

Engineered Myeloid Progenitor Platform Overcomes Allogeneic Barriers in CNS Tumors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.